Re: A Randomised Phase I/II Trial to Evaluate the Efficacy and Safety of Orally Administered Oxalobacter formigenes to Treat Primary Hyperoxaluria.
Publication
, Journal Article
Assimos, DG
Published in: J Urol
June 2017
Duke Scholars
Published In
J Urol
DOI
EISSN
1527-3792
Publication Date
June 2017
Volume
197
Issue
6
Start / End Page
1463
Location
United States
Related Subject Headings
- Urology & Nephrology
- Oxalobacter formigenes
- Oxalates
- Hyperoxaluria, Primary
- Hyperoxaluria
- Humans
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Assimos, D. G. (2017). Re: A Randomised Phase I/II Trial to Evaluate the Efficacy and Safety of Orally Administered Oxalobacter formigenes to Treat Primary Hyperoxaluria. J Urol, 197(6), 1463. https://doi.org/10.1016/j.juro.2017.03.083
Assimos, Dean G. “Re: A Randomised Phase I/II Trial to Evaluate the Efficacy and Safety of Orally Administered Oxalobacter formigenes to Treat Primary Hyperoxaluria.” J Urol 197, no. 6 (June 2017): 1463. https://doi.org/10.1016/j.juro.2017.03.083.
Assimos DG. Re: A Randomised Phase I/II Trial to Evaluate the Efficacy and Safety of Orally Administered Oxalobacter formigenes to Treat Primary Hyperoxaluria. J Urol. 2017 Jun;197(6):1463.
Assimos, Dean G. “Re: A Randomised Phase I/II Trial to Evaluate the Efficacy and Safety of Orally Administered Oxalobacter formigenes to Treat Primary Hyperoxaluria.” J Urol, vol. 197, no. 6, June 2017, p. 1463. Pubmed, doi:10.1016/j.juro.2017.03.083.
Assimos DG. Re: A Randomised Phase I/II Trial to Evaluate the Efficacy and Safety of Orally Administered Oxalobacter formigenes to Treat Primary Hyperoxaluria. J Urol. 2017 Jun;197(6):1463.
Published In
J Urol
DOI
EISSN
1527-3792
Publication Date
June 2017
Volume
197
Issue
6
Start / End Page
1463
Location
United States
Related Subject Headings
- Urology & Nephrology
- Oxalobacter formigenes
- Oxalates
- Hyperoxaluria, Primary
- Hyperoxaluria
- Humans
- 3202 Clinical sciences
- 1103 Clinical Sciences